There is not a good biomaker that is closely related to survival time for bladder cancer
(BLCA), The aim of the study is to identify a miRNA signature that could predict prognosis in …

Background This study aimed to construct prognostic model by screening prognostic miRNA
signature of bladder cancer. Methods The miRNA expression profile data of bladder cancer …

Objective: To develop a prognostic signature for patients with bladder cancer (BC). Methods:
We identified differentially expressed miRNAs between normal bladder tissue and bladder …

Background There is increasing evidence to suggest that miRNAs play an important role in
predicting cancer survival. To identify a panel of miRNA signature that can divided tumor …

A number of studies has shown that long non-coding RNAs (lncRNAs), microRNAs
(miRNAs) and protein coding genes (PCGs) are involved in various pathophysiological …

Background: Bladder carcinoma (BC) represents one of the most prevalent malignant
cancers, while predicting its clinical outcomes using traditional indicators is difficult. This …

Bladder urothelial carcinoma (BLC) is one of the most common cancers in men, and its
heterogeneity challenges the treatment to cure this disease. Recently, microRNAs (miRNAs) …

Bladder cancer is the most common malignant tumor of the urinary system, and it is also an
important cause of death by cancer globally. Increasing number of studies have shown that …

Introduction and Objectives. MicroRNA (miRNA) expression is altered in urologic
malignancies, including urothelial carcinoma of the bladder (UCB). Individual miRNAs have …

Bladder cancer (BC) is a common urinary system tumor with high aggressiveness, and it
results in relatively high mortality due to a lack of precise and suitable biomarkers. In this …